BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 22301831)

  • 1. Screening mammography use among current, former, and never hormone therapy users may not explain recent declines in breast cancer incidence.
    Buist DS; Walker R; Bowles EJ; Carney PA; Taplin SH; Onega T; Kerlikowske K; Clinton W; Miglioretti DL
    Cancer Epidemiol Biomarkers Prev; 2012 May; 21(5):720-7. PubMed ID: 22301831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in detection of invasive cancer and ductal carcinoma in situ at biennial screening mammography in Spain: a retrospective cohort study.
    Román M; Rué M; Sala M; Ascunce N; Baré M; Baroja A; De la Vega M; Galcerán J; Natal C; Salas D; Sánchez-Jacob M; Zubizarreta R; Castells X;
    PLoS One; 2013; 8(12):e83121. PubMed ID: 24376649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term outcomes of screening mammography using computer-aided detection: a population-based study of medicare enrollees.
    Fenton JJ; Xing G; Elmore JG; Bang H; Chen SL; Lindfors KK; Baldwin LM
    Ann Intern Med; 2013 Apr; 158(8):580-7. PubMed ID: 23588746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in invasive breast cancer and ductal carcinoma in situ rates in relation to the decline in hormone therapy use.
    Farhat GN; Walker R; Buist DS; Onega T; Kerlikowske K
    J Clin Oncol; 2010 Dec; 28(35):5140-6. PubMed ID: 21060026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The contribution of mammography screening to breast cancer incidence trends in the United States: an updated age-period-cohort model.
    Gangnon RE; Sprague BL; Stout NK; Alagoz O; Weedon-Fekjær H; Holford TR; Trentham-Dietz A
    Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):905-12. PubMed ID: 25787716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status.
    Miglioretti DL; Zhu W; Kerlikowske K; Sprague BL; Onega T; Buist DS; Henderson LM; Smith RA;
    JAMA Oncol; 2015 Nov; 1(8):1069-77. PubMed ID: 26501844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mammography screening detection of ductal carcinoma in situ and invasive breast cancer according to women's characteristics: is it the same?
    Théberge I; Vandal N; Guertin MH; Perron L
    Breast Cancer Res Treat; 2019 Apr; 174(2):525-535. PubMed ID: 30564969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of estrogen replacement therapy on the specificity and sensitivity of screening mammography.
    Laya MB; Larson EB; Taplin SH; White E
    J Natl Cancer Inst; 1996 May; 88(10):643-9. PubMed ID: 8627640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation in detection of ductal carcinoma in situ during screening mammography: a survey within the International Cancer Screening Network.
    Lynge E; Ponti A; James T; Májek O; von Euler-Chelpin M; Anttila A; Fitzpatrick P; Frigerio A; Kawai M; Scharpantgen A; Broeders M; Hofvind S; Vidal C; Ederra M; Salas D; Bulliard JL; Tomatis M; Kerlikowske K; Taplin S;
    Eur J Cancer; 2014 Jan; 50(1):185-92. PubMed ID: 24041876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimates of over-diagnosis of breast cancer due to population-based mammography screening in South Australia after adjustment for lead time effects.
    Beckmann K; Duffy SW; Lynch J; Hiller J; Farshid G; Roder D
    J Med Screen; 2015 Sep; 22(3):127-35. PubMed ID: 25896926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ductal carcinoma in situ: risk factors and impact of screening.
    Virnig BA; Wang SY; Shamilyan T; Kane RL; Tuttle TM
    J Natl Cancer Inst Monogr; 2010; 2010(41):113-6. PubMed ID: 20956813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of ductal carcinoma in situ in women undergoing screening mammography.
    Ernster VL; Ballard-Barbash R; Barlow WE; Zheng Y; Weaver DL; Cutter G; Yankaskas BC; Rosenberg R; Carney PA; Kerlikowske K; Taplin SH; Urban N; Geller BM
    J Natl Cancer Inst; 2002 Oct; 94(20):1546-54. PubMed ID: 12381707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: a retrospective population-based study.
    Duffy SW; Dibden A; Michalopoulos D; Offman J; Parmar D; Jenkins J; Collins B; Robson T; Scorfield S; Green K; Hall C; Liao XH; Ryan M; Johnson F; Stevens G; Kearins O; Sellars S; Patnick J
    Lancet Oncol; 2016 Jan; 17(1):109-14. PubMed ID: 26655422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of invasive breast cancer and ductal carcinoma in situ in a screening program by age: should older women continue screening?
    Erbas B; Amos A; Fletcher A; Kavanagh AM; Gertig DM
    Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1569-73. PubMed ID: 15466971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stage-specific breast cancer incidence rates among participants and non-participants of a population-based mammographic screening program.
    Hofvind S; Lee CI; Elmore JG
    Breast Cancer Res Treat; 2012 Aug; 135(1):291-9. PubMed ID: 22833199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent trends in hormone therapy utilization and breast cancer incidence rates in the high incidence population of Marin County, California.
    Ereman RR; Prebil LA; Mockus M; Koblick K; Orenstein F; Benz C; Clarke CA
    BMC Public Health; 2010 Apr; 10():228. PubMed ID: 20433756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population.
    Kerlikowske K; Miglioretti DL; Buist DS; Walker R; Carney PA;
    J Natl Cancer Inst; 2007 Sep; 99(17):1335-9. PubMed ID: 17698950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathologic findings from the Breast Cancer Surveillance Consortium: population-based outcomes in women undergoing biopsy after screening mammography.
    Weaver DL; Rosenberg RD; Barlow WE; Ichikawa L; Carney PA; Kerlikowske K; Buist DS; Geller BM; Key CR; Maygarden SJ; Ballard-Barbash R
    Cancer; 2006 Feb; 106(4):732-42. PubMed ID: 16411214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in incidence and detection of advanced breast cancer at biennial screening mammography in The Netherlands: a population based study.
    Nederend J; Duijm LE; Voogd AC; Groenewoud JH; Jansen FH; Louwman MW
    Breast Cancer Res; 2012 Jan; 14(1):R10. PubMed ID: 22230363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First epidemiological analysis of breast cancer incidence and tumor characteristics after implementation of population-based digital mammography screening.
    Weigel S; Batzler WU; Decker T; Hense HW; Heindel W
    Rofo; 2009 Dec; 181(12):1144-50. PubMed ID: 19859859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.